Maranda B, Labbe SM, Lurquin M, Brabant P, et al. Safety and efficacy of inhaled IBIO123 for mild-to-moderate COVID-19: a randomised, double-blind, dose-ascending, placebo-controlled, phase 1/2 trial. Lancet Infect Dis 2023 Aug 21:S1473-3099(23)00393.
PMID: 37619584